Central catheter-associated bloodstream infection (CLABSI)
Conditions
Interventions
Experimental group 1:ARROW AGB+drug coated central venous catheter placed in internal jugular vein (surgical pre catheter)
Experimental group 2:ARROW AGB+drug coated central venous catheter placed in the internal jugular vein (catheterization after surgery)
Control group 1:ARROW common central venous catheter placed in internal jugular vein (surgical anterior catheter)
Control group 2:ARROW common central venous catheter placed in internal jugular vein (catheterization after surgery)
Sponsors
The First Affiliated Hospital of Suzhou University
Eligibility
Sex/Gender
All
Age
20 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1. Patients with digestive tract tumors undergoing elective surgery in the First Affiliated Hospital of Soochow University from January 2022 to December 2022; 2. Internal jugular vein dual-lumen central vein catheterization should be performed, and catheter indentation time >48h; 3. Aged 20-85 years, BMI 18-45kg /m^2; 4. Approved by the Medical Ethics Committee of the First Affiliated Hospital of Soochow University, and signed the informed letter.
Exclusion criteria
Exclusion criteria: 1. Patients with fever before surgery; 2. Systemic or local inflammation and infection; 3. Patients with speech, hearing, or mental disorders and loss of neurological function; 4. Obvious abnormal coagulation function.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| catheter-related infections; | — |
Countries
China
Contacts
Public ContactLiu Silan
The First Affiliated Hospital of Suzhou University
Outcome results
None listed